TY - JOUR
T1 - The origin and emergence of an HIV-1 epidemic:
T2 - from introduction to endemicity
AU - Bruhn, Christian Anders Wathne
AU - Audelin, Anne M.
AU - Helleberg, Marie
AU - Bjorn-Mortensen, Karen
AU - Obel, Niels
AU - Gerstoft, Jan
AU - Nielsen, Claus
AU - Melbye, Mads
AU - Medstrand, Patrik
AU - Gilbert, M. Thomas P.
AU - Esbjörnsson, Joakim
PY - 2014/4/24
Y1 - 2014/4/24
N2 - Objectives: To describe, at patient-level detail, the determining events and factors involved in the development of a country's HIV-1 epidemic. Design: Clinical information for all recorded Greenlandic HIV-1 patients was analysed and correlated with both novel and previously analysed pol sequences, representing more than half of the entire Greenlandic HIV-1 epidemic. Archival blood samples were sequenced to link early infection chain descriptions to the subsequent epidemic. Methods: In-depth phylogenetic analyses were used in synergy with clinical information to assess number of introductions of HIV-1 into Greenland, the source of geographic origin, time of epidemic introduction and its epidemiological characteristics such as initial transmission chain, geographic dispersal within Greenland, method of infection, cluster size, sociological and behavioural factors. Results: Despite its small population size and isolated geographic location, data support at least 25 introductions of HIV-1 into Greenland. Only a single of these led to an epidemic. This introduction occurred between 1985 and 1986, and the epidemic cluster is still active. Facilitating factors for the emergence and spread of the epidemic cluster include a rapid transition from MSM to heterosexual spread, high prevalence of other sexually transmitted diseases, rapid dispersal to larger cities and early emergence in a distinct subpopulation with high-risk behaviour including disregard for condomizing. Conclusions: The synergistic use of disparate data categories yields such unique detail, that the Greenland epidemic now serves as a model example for the epidemic emergence of HIV-1 in a society. This renders it suitable for testing of present and future sequence-based epidemiological methodologies.
AB - Objectives: To describe, at patient-level detail, the determining events and factors involved in the development of a country's HIV-1 epidemic. Design: Clinical information for all recorded Greenlandic HIV-1 patients was analysed and correlated with both novel and previously analysed pol sequences, representing more than half of the entire Greenlandic HIV-1 epidemic. Archival blood samples were sequenced to link early infection chain descriptions to the subsequent epidemic. Methods: In-depth phylogenetic analyses were used in synergy with clinical information to assess number of introductions of HIV-1 into Greenland, the source of geographic origin, time of epidemic introduction and its epidemiological characteristics such as initial transmission chain, geographic dispersal within Greenland, method of infection, cluster size, sociological and behavioural factors. Results: Despite its small population size and isolated geographic location, data support at least 25 introductions of HIV-1 into Greenland. Only a single of these led to an epidemic. This introduction occurred between 1985 and 1986, and the epidemic cluster is still active. Facilitating factors for the emergence and spread of the epidemic cluster include a rapid transition from MSM to heterosexual spread, high prevalence of other sexually transmitted diseases, rapid dispersal to larger cities and early emergence in a distinct subpopulation with high-risk behaviour including disregard for condomizing. Conclusions: The synergistic use of disparate data categories yields such unique detail, that the Greenland epidemic now serves as a model example for the epidemic emergence of HIV-1 in a society. This renders it suitable for testing of present and future sequence-based epidemiological methodologies.
U2 - 10.1097/QAD.0000000000000198
DO - 10.1097/QAD.0000000000000198
M3 - Journal article
C2 - 24451158
SN - 1350-2840
VL - 28
SP - 1031
EP - 1040
JO - AIDS, Supplement
JF - AIDS, Supplement
IS - 7
ER -